On a quest to modernize cancer treatment and diagnosis, an MIT professor and her colleagues have created new nanoparticles that mimic blood platelets. The team wants to use these new multifunctional particles to carry out different medical missions inside the body, from imaging to drug delivery.
The American Cancer Society estimates that more than 178,000 women will be diagnosed with breast cancer and more than 40,000 will die as a result of breast cancer in 2007.
A breast cancer treatment based on MIT research originally intended for detecting missiles is documented in a new book by Alan J. Fenn, an MIT researcher and inventor of the technique.
Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies.
Researchers at the McGill Cancer Centre revealed they had managed to delay or completely suppress the onset of one particular strain of the breast cancer disease in lab mice.
Antibodies that selectively bind and destroy cancer cells represent some of the most promising cancer therapy approaches being developed today.
Mutant forms of the protein EGFR are important for the development of lung cancer in a substantial proportion of individuals with this disease. However, not all individuals express the same mutant EGFR, for example, some have a mutation that affects the intracellular part of EGFR and some have a mutation that affects the extracellular part of EGFR (known as the EGFRvIII mutant).
A new strategy for fighting cancer aims to make its genes get lost in translation, according to a report in the Jan. 26, 2007, issue of the journal Cell, published by Cell Press.
A team led by biochemists at the University of California, San Diego has found what could be a long-elusive mechanism through which inflammation can promote cancer.
Men who have been treated for breast cancer face a significantly high risk of getting cancer once again, according to UC Irvine epidemiologists.